185 related articles for article (PubMed ID: 30344013)
1. Assessing copy number abnormalities and copy-neutral loss-of-heterozygosity across the genome as best practice in diagnostic evaluation of acute myeloid leukemia: An evidence-based review from the cancer genomics consortium (CGC) myeloid neoplasms working group.
Xu X; Bryke C; Sukhanova M; Huxley E; Dash DP; Dixon-Mciver A; Fang M; Griepp PT; Hodge JC; Iqbal A; Jeffries S; Kanagal-Shamanna R; Quintero-Rivera F; Shetty S; Slovak ML; Yenamandra A; Lennon PA; Raca G
Cancer Genet; 2018 Dec; 228-229():218-235. PubMed ID: 30344013
[TBL] [Abstract][Full Text] [Related]
2. Assessing copy number aberrations and copy neutral loss of heterozygosity across the genome as best practice: An evidence based review of clinical utility from the cancer genomics consortium (CGC) working group for myelodysplastic syndrome, myelodysplastic/myeloproliferative and myeloproliferative neoplasms.
Kanagal-Shamanna R; Hodge JC; Tucker T; Shetty S; Yenamandra A; Dixon-McIver A; Bryke C; Huxley E; Lennon PA; Raca G; Xu X; Jeffries S; Quintero-Rivera F; Greipp PT; Slovak ML; Iqbal MA; Fang M
Cancer Genet; 2018 Dec; 228-229():197-217. PubMed ID: 30377088
[TBL] [Abstract][Full Text] [Related]
3. Assessing copy number aberrations and copy-neutral loss-of-heterozygosity across the genome as best practice: An evidence-based review from the Cancer Genomics Consortium (CGC) working group for chronic lymphocytic leukemia.
Chun K; Wenger GD; Chaubey A; Dash DP; Kanagal-Shamanna R; Kantarci S; Kolhe R; Van Dyke DL; Wang L; Wolff DJ; Miron PM
Cancer Genet; 2018 Dec; 228-229():236-250. PubMed ID: 30554732
[TBL] [Abstract][Full Text] [Related]
4. Clinical Applications of Chromosomal Microarray Testing in Myeloid Malignancies.
Ronaghy A; Yang RK; Khoury JD; Kanagal-Shamanna R
Curr Hematol Malig Rep; 2020 Jun; 15(3):194-202. PubMed ID: 32382988
[TBL] [Abstract][Full Text] [Related]
5. Technical laboratory standards for interpretation and reporting of acquired copy-number abnormalities and copy-neutral loss of heterozygosity in neoplastic disorders: a joint consensus recommendation from the American College of Medical Genetics and Genomics (ACMG) and the Cancer Genomics Consortium (CGC).
Mikhail FM; Biegel JA; Cooley LD; Dubuc AM; Hirsch B; Horner VL; Newman S; Shao L; Wolff DJ; Raca G
Genet Med; 2019 Sep; 21(9):1903-1916. PubMed ID: 31138931
[TBL] [Abstract][Full Text] [Related]
6. Broad copy neutral-loss of heterozygosity regions and rare recurring copy number abnormalities in normal karyotype-acute myeloid leukemia genomes.
Barresi V; Romano A; Musso N; Capizzi C; Consoli C; Martelli MP; Palumbo G; Di Raimondo F; Condorelli DF
Genes Chromosomes Cancer; 2010 Nov; 49(11):1014-23. PubMed ID: 20725993
[TBL] [Abstract][Full Text] [Related]
7. Assessing genome-wide copy number aberrations and copy-neutral loss-of-heterozygosity as best practice: An evidence-based review from the Cancer Genomics Consortium working group for plasma cell disorders.
Pugh TJ; Fink JM; Lu X; Mathew S; Murata-Collins J; Willem P; Fang M;
Cancer Genet; 2018 Dec; 228-229():184-196. PubMed ID: 30393007
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of previously cryptic copy number alterations and loss of heterozygosity in pediatric acute myeloid leukemia and myelodysplastic syndrome determined using combined array comparative genomic hybridization plus single-nucleotide polymorphism microarray analyses.
Koh KN; Lee JO; Seo EJ; Lee SW; Suh JK; Im HJ; Seo JJ
J Korean Med Sci; 2014 Jul; 29(7):926-33. PubMed ID: 25045224
[TBL] [Abstract][Full Text] [Related]
9. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
[TBL] [Abstract][Full Text] [Related]
10. Molecular evaluation of gene mutation profiles and copy number variations in pediatric acute myeloid leukemia.
Meena JP; Pathak N; Gupta AK; Bakhshi S; Gupta R; Makkar H; Seth R
Leuk Res; 2022 Nov; 122():106954. PubMed ID: 36162216
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of acquired copy-neutral loss of heterozygosity in acute myeloid leukemia.
Gronseth CM; McElhone SE; Storer BE; Kroeger KA; Sandhu V; Fero ML; Appelbaum FR; Estey EH; Fang M
Cancer; 2015 Sep; 121(17):2900-8. PubMed ID: 26033747
[TBL] [Abstract][Full Text] [Related]
12. Assessing Genomic Copy Number Alterations as Best Practice for Renal Cell Neoplasia: An Evidence-Based Review from the Cancer Genomics Consortium Workgroup.
Liu YJ; Houldsworth J; Emmadi R; Dyer L; Wolff DJ
Cancer Genet; 2020 Jun; 244():40-54. PubMed ID: 32434132
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide analysis of recurrent copy-number alterations and copy-neutral loss of heterozygosity in head and neck squamous cell carcinoma.
Marescalco MS; Capizzi C; Condorelli DF; Barresi V
J Oral Pathol Med; 2014 Jan; 43(1):20-7. PubMed ID: 23750501
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal microarray analysis is superior in identifying cryptic aberrations in patients with acute lymphoblastic leukemia at diagnosis/relapse as a single assay.
Chen C; Heng EYH; Lim AST; Lau LC; Lim TH; Wong GC; Tien SL
Int J Lab Hematol; 2019 Aug; 41(4):561-571. PubMed ID: 31112375
[TBL] [Abstract][Full Text] [Related]
15. aCNViewer: Comprehensive genome-wide visualization of absolute copy number and copy neutral variations.
Renault V; Tost J; Pichon F; Wang-Renault SF; Letouzé E; Imbeaud S; Zucman-Rossi J; Deleuze JF; How-Kit A
PLoS One; 2017; 12(12):e0189334. PubMed ID: 29261730
[TBL] [Abstract][Full Text] [Related]
16. Pretransplant HLA typing revealed loss of heterozygosity in the major histocompatibility complex in a patient with acute myeloid leukemia.
Lobashevsky AL; Krueger-Sersen M; Britton RM; Littrell CA; Singh S; Cui CP; Kashi Z; Martin RK; Breman AM; Vance GH; Farag SS
Hum Immunol; 2019 Apr; 80(4):257-262. PubMed ID: 30790598
[TBL] [Abstract][Full Text] [Related]
17. FLT3 and JAK2 Mutations in Acute Myeloid Leukemia Promote Interchromosomal Homologous Recombination and the Potential for Copy Neutral Loss of Heterozygosity.
Gaymes TJ; Mohamedali A; Eiliazadeh AL; Darling D; Mufti GJ
Cancer Res; 2017 Apr; 77(7):1697-1708. PubMed ID: 28108507
[TBL] [Abstract][Full Text] [Related]
18. Renal angiomyolipoma (AML) harboring a missense mutation of
Idogawa M; Hida T; Tanaka T; Ohira N; Tange S; Sasaki Y; Uhara H; Masumori N; Tokino T; Natori H
Cancer Biol Ther; 2020 Apr; 21(4):315-319. PubMed ID: 31847710
[TBL] [Abstract][Full Text] [Related]
19. Genome-Wide Copy Number Variation Detection Using NGS: Data Analysis and Interpretation.
Shen W; Szankasi P; Durtschi J; Kelley TW; Xu X
Methods Mol Biol; 2019; 1908():113-124. PubMed ID: 30649724
[TBL] [Abstract][Full Text] [Related]
20. Difference of genomic copy numbers alterations between hairy cell leukemia-variant and classical hairy cell leukemia: a pilot retrospective study in Chinese.
Zhang R; Wu Y; Wang X; Lu X; Li Y; Li S; Yan X
Int J Med Sci; 2020; 17(3):325-331. PubMed ID: 32132867
[No Abstract] [Full Text] [Related]
[Next] [New Search]
